Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Objective To evaluate whether the addition of colchicine to standard treatment for COVID-19 results in better outcomes.Design We present the results of a randomised, double-blinded, placebo-controlled clinical trial of colchicine for the treatment of moderate to severe COVID-19, with 75 patients all...
Main Authors: | Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, Natalia B Amaral, Pamella Indira Menezes, Saulo Musse Dib, Samara Libich Gigante, Maira N Benatti, Uebe C Rezek, Laerte L Emrich-Filho, Betania A A Sousa, Sergio C L Almeida, Rodrigo Luppino Assad, Flavio P Veras, Ayda Schneider, Tamara S Rodrigues, Luiz O S Leiria, Larissa D Cunha, Jose C Alves-Filho, Thiago M Cunha, Eurico Arruda, Carlos H Miranda, Antonio Pazin-Filho, Maria Auxiliadora-Martins, Marcos C Borges, Benedito A L Fonseca, Valdes R Bollela, Cristina M Del-Ben, Fernando Q Cunha, Dario S Zamboni, Rodrigo C Santana, Fernando C Vilar, Paulo Louzada-Junior, Rene D R Oliveira |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-04-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/7/1/e001455.full |
Similar Items
-
A Comunicação Vigiada: nota sobre a suspeição na Cibercultura
by: Paulo C. Cunha Filho
Published: (2004-01-01) -
Severe hypertriglyceridemia and colchicine intoxication following suicide attempt
by: Lev S, et al.
Published: (2017-11-01) -
Biorhizome: A Biosynthetic Platform for Colchicine Biomanufacturing
by: Ganapathy Sivakumar, et al.
Published: (2017-06-01) -
Colchicine plus Dapsone in Colchicine‐Resistant FMF Patients
by: Farhad Salehzadeh, et al.
Published: (2019-01-01) -
Utilização de ciclodextrinas na formação de complexos de inclusão de interesse farmacêutico
by: M.S.S. Cunha-Filho, et al.
Published: (2007-01-01)